Manish Mital
@Braidwell Lp
Latest period2024 - Q3ReportedManaged Assets$3.528BTotal holdings81
Assets growth rate10.68%Assets growth rate (2-Q avg)6.71%Continuous growth in asset value3 quarters
Portfolio positions
This chart displays the top 10 holdings in Braidwell Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.
Assets under management
The assets under management (AUM) of Braidwell Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.528B in assets, with a quarterly growth rate of 10.68% and a 2-quarter average growth rate of 6.71%. The portfolio is managed by Manish Mital, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
MRVIMaravai Lifesciences Hldgs I
| 1.97% | $69.416M 8.353M shares@ $8.32 avg price | Decreased -7.43% |
DAWNDay One Biopharmaceuticals I
| 1.93% | $67.893M 4.874M shares@ $13.93 avg price | Increased 60.55% |
SYRESpyre Therapeutics Inc
| 1.83% | $64.403M 2.19M shares@ $29.42 avg price | Decreased -12.91% |
RGENRepligen Corp
| 1.68% | $59.049M 396,781 shares@ $148.82 avg price | Increased 22.65% |
IRTCIrhythm Technologies Inc
| 1.65% | $58.097M 782,557 shares@ $74.25 avg price | Increased 48.68% |
7612⤦Travere Therapeutics Inc
| 1.52% | $53.538M 56.031M shares@ $0.96 avg price | |
0208⤦Alphatec Hldgs Inc
| 1.49% | $52.511M 58.217M shares@ $0.91 avg price | |
ARGXArgenx Se
| 1.49% | $52.432M 96,724 shares@ $542.09 avg price | Decreased -42.05% |
EWTXEdgewise Therapeutics Inc
| 1.49% | $52.267M 1.958M shares@ $26.7 avg price | New Position |
INSPInspire Med Sys Inc
| 1.43% | $50.422M 238,911 shares@ $211.06 avg price | Decreased -37.03% |